J. Wittwer, K. Webster, and H. Menz, A longitudinal study of measures of walking in people with Alzheimer's Disease, Gait & Posture, vol.32, issue.1, pp.113-117, 2010.
DOI : 10.1016/j.gaitpost.2010.04.001

A. Pettersson, E. Olsson, and L. Wahlund, Motor Function in Subjects with Mild Cognitive Impairment and Early Alzheimer???s Disease, Dementia and Geriatric Cognitive Disorders, vol.19, issue.5-6, pp.299-304, 2005.
DOI : 10.1159/000084555

L. Eggermont, B. Gavett, K. Volkers, C. Blankevoort, E. Scherder et al., Lower-Extremity Function in Cognitively Healthy Aging, Mild Cognitive Impairment, and Alzheimer's Disease, Archives of Physical Medicine and Rehabilitation, vol.91, issue.4, pp.584-588, 2010.
DOI : 10.1016/j.apmr.2009.11.020

N. Nadkarni, E. Mawji, W. Mcilroy, and S. Black, Spatial and temporal gait parameters in Alzheimer's disease and aging, Gait & Posture, vol.30, issue.4, pp.452-454, 2009.
DOI : 10.1016/j.gaitpost.2009.07.003

N. Alexander, Gait Disorders in Older Adults, Journal of the American Geriatrics Society, vol.8, issue.suppl, pp.434-451, 1996.
DOI : 10.1111/j.1532-5415.1996.tb06417.x

C. Andersen, K. Wittrup-jensen, A. Lolk, K. Andersen, and P. Kragh-sorensen, Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia, Health and Quality of Life Outcomes, vol.2, issue.1, p.52, 2004.
DOI : 10.1186/1477-7525-2-52

D. Knopman, J. Berg, R. Thomas, M. Grundman, L. Thal et al., Nursing home placement is related to dementia progression: Experience from a clinical trial, Neurology, vol.52, issue.4, pp.714-718, 1999.
DOI : 10.1212/WNL.52.4.714

P. Van-dijk, D. Mehr, M. Ooms, R. Madsen, G. Petroski et al., Comorbidity and 1-Year Mortality Risks in Nursing Home Residents, Journal of the American Geriatrics Society, vol.36, issue.4, pp.660-665, 2005.
DOI : 10.1111/j.1532-5415.2005.53216.x

H. Prigerson, Costs to Society of Family Caregiving for Patients with End-Stage Alzheimer's Disease, New England Journal of Medicine, vol.349, issue.20, pp.1891-1892, 2003.
DOI : 10.1056/NEJMp038157

L. Allan, C. Ballard, D. Burn, and R. Kenny, Prevalence and Severity of Gait Disorders in Alzheimer's and Non-Alzheimer's Dementias, Journal of the American Geriatrics Society, vol.34, issue.10, pp.1681-1687, 2005.
DOI : 10.1111/j.1532-5415.2005.53552.x

D. Burn, E. Rowan, L. Allan, S. Molloy, O. Brien et al., Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.5, pp.585-589, 2006.
DOI : 10.1136/jnnp.2005.081711

J. Mossey, R. Gallagher, and F. Tirumalasetti, The Effects of Pain and Depression on Physical Functioning in Elderly Residents of a Continuing Care Retirement Community, Pain Medicine, vol.1, issue.4, pp.340-350, 2000.
DOI : 10.1046/j.1526-4637.2000.00040.x

S. Gillette-guyonnet, F. Nourhashemi, S. Andrieu, C. Cantet, M. Micas et al., Vellas B: The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results, J Nutr Health Aging, vol.7, pp.91-96, 2003.

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, pp.939-944, 1984.
DOI : 10.1212/WNL.34.7.939

S. Katz, A. Ford, R. Moskowitz, B. Jackson, and M. Jaffe, Studies of Illness in the Aged, JAMA, vol.185, issue.12, pp.914-919, 1963.
DOI : 10.1001/jama.1963.03060120024016

S. Zarit, K. Reever, and J. Bach-peterson, Relatives of the Impaired Elderly: Correlates of Feelings of Burden, The Gerontologist, vol.20, issue.6, pp.649-655, 1980.
DOI : 10.1093/geront/20.6.649

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

J. Cummings, M. Mega, K. Gray, S. Rosenberg-thompson, D. Carusi et al., The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia, Neurology, vol.44, issue.12, pp.2308-2314, 1994.
DOI : 10.1212/WNL.44.12.2308

Y. Guigoz, S. Lauque, and B. Vellas, Identifying the elderly at risk for malnutrition, Clinics in Geriatric Medicine, vol.18, issue.4, pp.737-757, 2002.
DOI : 10.1016/S0749-0690(02)00059-9

B. Vellas, S. Wayne, L. Romero, R. Baumgartner, L. Rubenstein et al., One-Leg Balance Is an Important Predictor of Injurious Falls in Older Persons, Journal of the American Geriatrics Society, vol.35, issue.6, pp.735-738, 1997.
DOI : 10.1111/j.1532-5415.1997.tb01479.x

L. Desquilbet and L. Meyer, Time-dependent covariates in the Cox proportional hazards model. Theory and practice. Rev Epidemiol Sante Publique, pp.51-68, 2005.

S. Potkin, The ABC of Alzheimers Disease: ADL and Improving Day-to-Day Functioning of Patients, International Psychogeriatrics, vol.14, issue.S1, pp.7-26, 2002.
DOI : 10.1017/S1041610203008640

N. Scarmeas, G. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin et al., Motor signs during the course of Alzheimer disease, Neurology, vol.63, issue.6, pp.975-982, 2004.
DOI : 10.1212/01.WNL.0000138440.39918.0C

L. Hebert, P. Scherr, J. Mccann, J. Bienias, and D. Evans, Change in direct measures of physical performance among persons with Alzheimer's disease, Aging & Mental Health, vol.47, issue.6, pp.729-734, 2008.
DOI : 10.2307/2531248

C. Karvonen-gutierrez and K. Ylitalo, Prevalence and Correlates of Disability in a Late Middle-Aged Population of Women, Journal of Aging and Health, vol.177, issue.193, pp.701-717, 2013.
DOI : 10.1016/B978-012453790-3/50012-3

T. Gill, T. Murphy, E. Gahbauer, and H. Allore, Association of Injurious Falls With Disability Outcomes and Nursing Home Admissions in Community-Living Older Persons, American Journal of Epidemiology, vol.178, issue.3, pp.418-425, 2013.
DOI : 10.1093/aje/kws554

Y. Rolland, F. Pillard, V. Lauwers-cances, F. Busquere, B. Vellas et al., Rehabilitation outcome of elderly patients with hip fracture and cognitive impairment, Disability and Rehabilitation, vol.1, issue.7, pp.425-431, 2004.
DOI : 10.1159/000017108

A. Burns, M. Rossor, J. Hecker, S. Gauthier, H. Petit et al., The Effects of Donepezil in Alzheimer???s Disease ??? Results from a Multinational Trial¹, Dementia and Geriatric Cognitive Disorders, vol.10, issue.3, pp.237-244, 1999.
DOI : 10.1159/000017126

H. Feldman, S. Gauthier, J. Hecker, B. Vellas, P. Subbiah et al., A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease, Neurology, vol.57, issue.4, pp.613-620, 2001.
DOI : 10.1212/WNL.57.4.613

G. Wilcock, S. Lilienfeld, and E. Gaens, Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial, BMJ, vol.321, issue.7274, pp.1445-1449, 2000.
DOI : 10.1136/bmj.321.7274.1445

P. Tariot, J. Cummings, I. Katz, J. Mintzer, C. Perdomo et al., A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting, Journal of the American Geriatrics Society, vol.4, issue.Suppl. 2, pp.1590-1599, 2001.
DOI : 10.1111/j.1532-5415.2001.49266.x

R. Hansen, G. Gartlehner, K. Lohr, and D. Kaufer, Functional Outcomes of Drug Treatment in Alzheimer???s Disease, Drugs & Aging, vol.31, issue.1, pp.155-167, 2007.
DOI : 10.2165/00002512-200724020-00007

D. Munoz-torrero, Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer???s Disease, Curr Med Chem, vol.15, pp.2433-2455, 2008.
DOI : 10.2174/9781608059706115070004

J. Birks, Cholinesterase inhibitors for Alzheimer's disease, Cochrane Database Syst Rev, vol.11, issue.suppl 2, 2006.
DOI : 10.1002/14651858.CD005593

B. Vellas, L. Cunha, H. Gertz, D. Deyn, P. Wesnes et al., Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease, Current Medical Research and Opinion, vol.21, issue.9, pp.1423-1429, 2005.
DOI : 10.1185/030079905X61884

F. Assal, G. Allali, R. Kressig, F. Herrmann, and O. Beauchet, GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE, Journal of the American Geriatrics Society, vol.16, issue.5, pp.946-947, 2008.
DOI : 10.1111/j.1532-5415.2008.01657.x

G. Grossberg, The ABC of Alzheimers Disease: Behavioral Symptoms and Their Treatment, International Psychogeriatrics, vol.14, issue.S1, pp.27-49, 2002.
DOI : 10.1017/S1041610203008652

A. Roher, C. Esh, T. Kokjohn, E. Castano, V. Vickle et al., Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease, Alzheimer's & Dementia, vol.5, issue.1, pp.18-29, 2009.
DOI : 10.1016/j.jalz.2008.10.004

H. Ogura, T. Kosasa, Y. Kuriya, and Y. Yamanishi, Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats, European Journal of Pharmacology, vol.415, issue.2-3, pp.157-164, 2001.
DOI : 10.1016/S0014-2999(01)00824-X

V. Lyell, K. Ranatunga, and T. Allain, CHOLINESTERASE INHIBITORS AND PERIPHERAL NEUROMUSCULAR FUNCTION IN DEMENTIA, Journal of the American Geriatrics Society, vol.197, issue.(S, pp.2354-2356, 2009.
DOI : 10.1111/j.1532-5415.2009.02598.x

A. Koyama, J. O-'brien, J. Weuve, D. Blacker, A. Metti et al., The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.68, issue.4, pp.433-440, 2013.
DOI : 10.1093/gerona/gls187

V. Pavlov and K. Tracey, Controlling inflammation: the cholinergic anti-inflammatory pathway: Figure 1, Biochemical Society Transactions, vol.34, issue.6, pp.1037-1040, 2006.
DOI : 10.1042/BST0341037

M. Arikawa, Y. Kakinuma, T. Handa, F. Yamasaki, and T. Sato, Donepezil, Anti-Alzheimer's Disease Drug, Prevents Cardiac Rupture during Acute Phase of Myocardial Infarction in Mice, PLoS ONE, vol.40, issue.7, p.20629, 2011.
DOI : 10.1371/journal.pone.0020629.t003

V. Gardette, S. Andrieu, M. Lapeyre-mestre, N. Coley, C. Cantet et al., Predictive Factors of Discontinuation and Switch of Cholinesterase Inhibitors in Community-Dwelling Patients with Alzheimer??s Disease, CNS Drugs, vol.25, issue.10, pp.431-442, 2010.
DOI : 10.2165/11318010-000000000-00000